Cargando…

First Results From a Propensity Matching Trial of Mycophenolate Mofetil vs. Azathioprine in Treatment-Naive AIH Patients

BACKGROUND/AIMS: As previous real-world studies and meta-analyses have shown that mycophenolate mofetil (MMF) might have better efficacy than azathioprine (AZA) in autoimmune hepatitis (AIH), we conducted a propensity matching study to assess the efficacy and safety of MMF vs. AZA. METHODS: All 126...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dalekos, George N., Arvaniti, Pinelopi, Gatselis, Nikolaos K., Samakidou, Anna, Gabeta, Stella, Rigopoulou, Eirini, Koukoulis, George K., Zachou, Kalliopi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787111/ https://www.ncbi.nlm.nih.gov/pubmed/35087524 http://dx.doi.org/10.3389/fimmu.2021.798602

Ejemplares similares

Long-term results of mycophenolate mofetil vs. azathioprine use in individuals with autoimmune hepatitis
por: Dalekos, George N., et al.
Publicado: (2022)

FibroMeter scores are predictive noninvasive markers of advanced and significant liver fibrosis in patients with chronic viral hepatitis or metabolic dysfunction-associated steatotic liver disease
por: Arvaniti, Pinelopi, et al.
Publicado: (2023)

Belimumab is a promising third-line treatment option for refractory autoimmune hepatitis
por: Arvaniti, Pinelopi, et al.
Publicado: (2020)

Patients with Haemoglobinopathies and Chronic Hepatitis C: A Real Difficult to Treat Population in 2016?
por: Zachou, Kalliopi, et al.
Publicado: (2017)

Postinfantile Giant Cell Hepatitis with Features of Acute Severe Autoimmune Hepatitis Probably Triggered by Diclofenac in a Patient with Primary Myelofibrosis
por: Arvaniti, Pinelopi, et al.
Publicado: (2018)

The changing epidemiology of hepatitis B in Greece
por: Rigopoulou, Eirini I., et al.
Publicado: (2021)

Epigenetic Modifications in Generalized Autoimmune Epithelitis: Sjögren’s Syndrome and Primary Biliary Cholangitis
por: Arvaniti, Pinelopi, et al.
Publicado: (2019)

Serum Cartilage Oligomeric Matrix Protein and Golgi Protein-73: New Diagnostic and Predictive Tools for Liver Fibrosis and Hepatocellular Cancer?
por: Gatselis, Nikolaos K., et al.
Publicado: (2021)

Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease
por: Zachou, Kalliopi, et al.
Publicado: (2004)

Impact of genetic and environmental factors on autoimmune hepatitis
por: Zachou, Kalliopi, et al.
Publicado: (2021)

Acute non-A, non-B, non-C hepatitis differences and similarities between hepatitis E virus infection and autoimmune hepatitis, with phylogenetic analysis of hepatitis E virus in humans and wild boars
por: Zachou, Kalliopi, et al.
Publicado: (2022)

Efficient management of secondary haemophagocytic lymphohistiocytosis with intravenous steroids and γ-immunoglobulin infusions
por: Georgiadou, Sarah, et al.
Publicado: (2019)

The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders
por: Papamichalis, Panagiotis A, et al.
Publicado: (2007)

The Influence of Mycophenolate Mofetil and Azathioprine on the Same Cadaveric Donor Renal Transplantation
por: Joh, Jae Won, et al.
Publicado: (2005)

Low Serum Hepcidin in Patients with Autoimmune Liver Diseases
por: Lyberopoulou, Aggeliki, et al.
Publicado: (2015)

Early Primary Biliary Cirrhosis: A New Association with Erythema Nodosum of Unknown Origin
por: Gatselis, Nikolaos K., et al.
Publicado: (2010)

Comparison of azathioprine with mycophenolate mofetil in a living donor kidney transplant programme
por: Bansal, S. B., et al.
Publicado: (2011)

Promyelocytic Leukemia Antigen Expression: a Histological Marker for Primary Biliary Cholangitis Diagnosis?
por: Papamichalis, Panagiotis A., et al.
Publicado: (2021)

Azathioprine/methylprednisolone/mycophenolate-mofetil: COVID-19 respiratory infection: 2 case reports
Publicado: (2021)

Comparative Efficacy and Safety of Mycophenolate Mofetil and Azathioprine in Combination with Corticosteroids in the Treatment of Lymphocytic Myocarditis
por: Blagova, Olga, et al.
Publicado: (2023)

Severe Pharyngodynia Followed by Migratory Polyarthritis and High Fever in Young Immigrants: Remember That Rheumatic Fever Is Still Relevant in 2020!
por: Azariadis, Kalliopi, et al.
Publicado: (2020)

Safety and Efficacy of Transcatheter Arterial Chemoemboliazation in the Real-Life Management of Unresectable Hepatocellular Carcinoma
por: Mazioti, Argyro, et al.
Publicado: (2013)

Features and outcome of AIH patients without elevation of IgG
por: Hartl, Johannes, et al.
Publicado: (2020)

Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients
por: Gatselis, Nikolaos K, et al.
Publicado: (2020)

A Comparison of Azathioprine and Mycophenolate Mofetil as Adjuvant Drugs in Patients with Pemphigus: A Retrospective Cohort Study
por: Sukanjanapong, Siriorn, et al.
Publicado: (2019)

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
por: Houssiau, Frédéric A, et al.
Publicado: (2010)

Cost-Utility Analysis of Mycophenolate Mofetil versus Azathioprine Based Regimens for Maintenance Therapy of Proliferative Lupus Nephritis
por: Nee, Robert, et al.
Publicado: (2015)

Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis
por: Tamirou, Farah, et al.
Publicado: (2016)

Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2011)

JAK Inhibitors and Oxidative Stress Control
por: Charras, Amandine, et al.
Publicado: (2019)

Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022)

Mycophenolate mofetil in the treatment of lupus nephritis
por: Yong, Patrick FK, et al.
Publicado: (2008)

Severe Enteropathy From Mycophenolate Mofetil
por: Jehangir, Asad, et al.
Publicado: (2016)

Autoimmune Gastritis Treated With Mycophenolate Mofetil
por: Harb, Ali H., et al.
Publicado: (2020)

Mycophenolate mofetil: Cytopenia: case report
Publicado: (2021)

Mycophenolate mofetil in giant cell arteritis
por: Pankow, Anne, et al.
Publicado: (2023)

Lessons from pathophysiology: Use of individualized combination treatments with immune interventional agents to tackle severe respiratory failure in patients with COVID-19
por: Dalekos, George N., et al.
Publicado: (2021)

Pharmacokinetics of Mycophenolic Acid after Intravenous Administration of Mycophenolate Mofetil to Healthy Cats
por: Slovak, J.E., et al.
Publicado: (2017)

Spontaneous Cirrhosis Regression in an IFN-beta-induced AIH-like Syndrome Following Drug Withdrawal: Art of Facts or Artifacts?
por: Kalafateli, Maria, et al.
Publicado: (2016)

Mycophenolate-mofetil/mycophenolic-acid: COVID-19: 4 case reports
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hvmin6vk9g6li4ogg8sg5l8hnq